Clinical Trials Browser

Phase 1 × Chromosome Aberrations × Panobinostat × Clear all

NCT01242774 2020-12-19

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Phase 1 Completed

Other hematologic neoplasm

Chromosome Aberrations, Leukemia, Myeloid, Acute